The Janssen Pharmaceutical companies of Johnson & Johnson, Beerse, Belgium.
I-BioStat, KU Leuven, Leuven, Belgium.
Pharm Stat. 2021 Nov;20(6):1216-1231. doi: 10.1002/pst.2141. Epub 2021 May 21.
In the meta-analytic surrogate evaluation framework, the trial-level coefficient of determination quantifies the strength of the association between the expected causal treatment effects on the surrogate (S) and the true (T) endpoints. Burzykowski and Buyse supplemented this metric of surrogacy with the surrogate threshold effect (STE), which is defined as the minimum value of the causal treatment effect on S for which the predicted causal treatment effect on T exceeds zero. The STE supplements with a more direct clinically interpretable metric of surrogacy. Alonso et al. proposed to evaluate surrogacy based on the strength of the association between the individual (rather than expected) causal treatment effects on S and T. In the current paper, the individual-level surrogate threshold effect (ISTE) is introduced in the setting where S and T are normally distributed variables. ISTE is defined as the minimum value of the individual causal treatment effect on S for which the lower limit of the prediction interval around the individual causal treatment effect on T exceeds zero. The newly proposed methodology is applied in a case study, and it is illustrated that ISTE has an appealing clinical interpretation. The R package surrogate implements the methodology and a web appendix (supporting information) that details how the analyses can be conducted in practice is provided.
在荟萃分析替代评估框架中,试验水平决定系数量化了预期因果治疗效果对替代(S)和真实(T)终点之间关联的强度。Burzykowski 和 Buyse 用替代阈值效应(STE)补充了这个替代指标,STE 定义为 S 上因果治疗效果的最小值,此时预测 T 上因果治疗效果超过零。STE 用更直接的、临床可解释的替代指标进行了补充。Alonso 等人提出基于 S 和 T 上个体(而不是预期)因果治疗效果之间的关联强度来评估替代。在当前的论文中,在 S 和 T 正态分布变量的设置下引入了个体水平替代阈值效应(ISTE)。ISTE 定义为 S 上个体因果治疗效果的最小值,此时 T 上个体因果治疗效果的预测区间下限超过零。新提出的方法在一个案例研究中得到了应用,并说明 ISTE 具有吸引人的临床解释。R 包 surrogate 实现了该方法,并且提供了一个网络附录(支持信息),详细说明了如何在实践中进行分析。